Nordea Investment Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $877K | Buy |
+11,279
| New | +$959K | ﹤0.01% | 861 |
|
|
2023
Q2 | – | Sell |
-237,648
| Closed | -$13.3M | – | 962 |
|
|
2023
Q1 | $13.3M | Sell |
237,648
-566,998
| -70% | -$36.4M | 0.02% | 337 |
|
|
2022
Q4 | $59.2M | Sell |
804,646
-271,056
| -25% | -$18.5M | 0.09% | 207 |
|
|
2022
Q3 | $64.8M | Buy |
1,075,702
+110,347
| +11% | +$6.65M | 0.1% | 191 |
|
|
2022
Q2 | $54M | Sell |
965,355
-18,206
| -2% | -$1.2M | 0.08% | 208 |
|
|
2022
Q1 | $73.5M | Buy |
983,561
+162,812
| +20% | +$11.3M | 0.09% | 203 |
|
|
2021
Q4 | $59.7M | Buy |
820,749
+110,667
| +16% | +$8.03M | 0.07% | 229 |
|
|
2021
Q3 | $56.5M | Buy |
710,082
+21,045
| +3% | +$1.69M | 0.07% | 231 |
|
|
2021
Q2 | $53.4M | Sell |
689,037
-60,265
| -8% | -$4.28M | 0.07% | 232 |
|
|
2021
Q1 | $46M | Buy |
749,302
+31,813
| +4% | +$2.01M | 0.07% | 239 |
|
|
2020
Q4 | $46.8M | Buy |
717,489
+70,440
| +11% | +$4.05M | 0.08% | 227 |
|
|
2020
Q3 | $31.8M | Sell |
647,049
-556,119
| -46% | -$28.7M | 0.06% | 236 |
|
|
2020
Q2 | $56.6M | Buy |
1,203,168
+641,351
| +114% | +$30.9M | 0.06% | 227 |
|
|
2020
Q1 | $23.7M | Buy |
561,817
+196,203
| +54% | +$9.69M | 0.06% | 231 |
|
|
2019
Q4 | $21.5M | Buy |
365,614
+46,590
| +15% | +$2.53M | 0.04% | 271 |
|
|
2019
Q3 | $16.3M | Sell |
319,024
-15,468
| -5% | -$737K | 0.04% | 283 |
|
|
2019
Q2 | $14.2M | Buy |
334,492
+14,139
| +4% | +$614K | 0.03% | 304 |
|
|
2019
Q1 | $15.8M | Buy |
320,353
+50,492
| +19% | +$2.28M | 0.03% | 319 |
|
|
2018
Q4 | $11.7M | Buy |
269,861
+63,607
| +31% | +$3.17M | 0.03% | 342 |
|
|
2018
Q3 | $11.7M | Buy |
206,254
+125,274
| +155% | +$6.59M | 0.02% | 371 |
|
|
2018
Q2 | $4.09M | Buy |
80,980
+23,328
| +40% | +$1.22M | 0.01% | 495 |
|
|
2018
Q1 | $2.87M | Sell |
57,652
-15,862
| -22% | -$746K | 0.01% | 646 |
|
|
2017
Q4 | $3.02M | Sell |
73,514
-3,955
| -5% | -$138K | 0.01% | 513 |
|
|
2017
Q3 | $2.3M | Buy |
77,469
+54,368
| +235% | +$1.66M | 0.01% | 602 |
|
|
2017
Q2 | $766K | Sell |
23,101
-6,434
| -22% | -$202K | ﹤0.01% | 806 |
|
|
2017
Q1 | $875K | Sell |
29,535
-1,868
| -6% | -$51K | ﹤0.01% | 783 |
|
|
2016
Q4 | $779K | Sell |
31,403
-2,815
| -8% | -$64K | ﹤0.01% | 791 |
|
|
2016
Q3 | $772K | Buy |
34,218
+17,956
| +110% | +$422K | ﹤0.01% | 770 |
|
|
2016
Q2 | $388K | Buy |
16,262
+14,835
| +1,040% | +$356K | ﹤0.01% | 798 |
|
|
2016
Q1 | $34K | Buy |
+1,427
| New | +$34.9K | ﹤0.01% | 950 |
|
Other funds holding GMED
JT
SC
Nordea Investment Management's GMED Position: Q2 2026 in Review
Nordea Investment Management opened a new position in Globus Medical (GMED) in Q2 2026: 11,279 shares worth $877K. The stake represents ﹤0.01% of the portfolio and ranks #861 among its holdings. This is a return to the name: Nordea Investment Management previously reported a position in GMED as recently as Q1 2023.
Nordea Investment Management first reported a position in GMED in Q1 2016 and has held it in 30 quarters since. The position peaked at $73.5M in Q1 2022. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Nordea Investment Management held 11,279 shares of Globus Medical worth $877K as of Q2 2026.
- Globus Medical was a new Nordea Investment Management position in Q2 2026.
- Globus Medical made up ﹤0.01% of Nordea Investment Management's portfolio in Q2 2026, its #861 holding.
- Nordea Investment Management first reported a position in Globus Medical in Q1 2016 and has held it in 30 quarters since.
- Nordea Investment Management's Globus Medical position peaked at $73.5M in Q1 2022.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.